Lenacapavir: Patient and healthcare provider perceptions and the potential role for a twice-yearly injectable HIV treatment.
Alford K. et al, (2025), HIV Med, 26, 441 - 450
HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.
Cargill T. et al, (2023), JHEP Rep, 5